Fibroblast growth factor 23 production in bone is directly regulated by 1{alpha},25-dihydroxyvitamin D, but not PTH. - Test2 - elhamkhani - TriplyDB

Fibroblast growth factor 23 production in bone is directly regulated by 1{alpha},25-dihydroxyvitamin D, but not PTH.

Fibroblast growth factor 23 production in bone is directly regulated by 1{alpha},25-dihydroxyvitamin D, but not PTH.

http://www.wikidata.org/entity/Q42925810

about

Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism Nuclear receptors in bone physiology and diseases Regulation and function of the FGF23/klotho endocrine pathways Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease Cardiovascular Risk Factors and Chronic Kidney Disease-FGF23: A Key Molecule in the Cardiovascular Disease 1,25-dihydroxyvitamin D(3) regulation of fibroblast growth factor-23 expression in bone cells: evidence for primary and secondary mechanisms modulated by leptin and interleukin-6 Intravenous phosphate loading increases fibroblast growth factor 23 in uremic rats The use of fibroblast growth factor 23 testing in patients with kidney disease.Effects of Different 1-34 Parathyroid Hormone Dosages on Fibroblast Growth Factor-23 Secretion in Human Bone Marrow Cells following Osteogenic Differentiation.Effects of high doses of cholecalciferol in normal subjects: a randomized double-blinded, placebo-controlled trial.FGF-23/Klotho signaling is not essential for the phosphaturic and anabolic functions of PTH.(1-34) Parathyroid hormone infusion acutely lowers fibroblast growth factor 23 concentrations in adult volunteers.FGF23 in skeletal modeling and remodeling.Calcium homeostasis may influence resting energy expenditure with effects most apparent in early pubertal girls.Metabolic acidosis increases fibroblast growth factor 23 in neonatal mouse bone Effect of cholecalciferol overdosage on pregnancy outcome in white albino mice.High phosphate feeding promotes mineral and bone abnormalities in mice with chronic kidney disease.Fibroblast growth factor-23: what we know, what we don't know, and what we need to know.Multiple faces of fibroblast growth factor-23 The rachitic tooth.Vitamin D endocrine system and osteocytes.FGF-23: the rise of a novel cardiovascular risk marker in CKD.Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.The dynamic skeleton.Sympathetic activation induces skeletal Fgf23 expression in a circadian rhythm-dependent manner.The bone and beyond: 'Dem bones' are made for more than walking.Reciprocal regulation of calcium-/phosphate-regulating hormones in cyclists during the Giro d'Italia 3-week stage race.The pathophysiology of early-stage chronic kidney disease-mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat.Fibroblast Growth Factor 23 Regulation by Systemic and Local Osteoblast-Synthesized 1,25-Dihydroxyvitamin D.Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model.The role of fibroblast growth factor-23 in cardiorenal syndrome.

P2860

Q26852624-FAC65634-3FB2-4A6D-B7EF-43EDFD1ABE22 Q26853017-C86A8830-2057-477E-A768-E85015CA6B9A Q26860470-925D236D-DE2C-4B67-B3ED-B1647C083B62 Q27000415-82A1FD0E-29C1-4D52-86C2-FA8F24420D7F Q27024043-40E95FFA-C9D3-43B5-8DDA-D2E948970098 Q28572351-BD410919-1CE7-4598-88BD-4896A0780964 Q28583506-24AAFD53-469F-494A-BB02-75B0A87FDB61 Q33835743-47F92FA5-AACA-4E06-9E54-7076580544E2 Q33851227-B7E47039-C2B4-45AB-89A5-FF64CC2D8B87 Q34104962-BFECAB0A-CAEB-4C40-8A38-9B350A510455 Q35129687-AB259AAB-05B2-4E64-83E8-CB0D40C64AFC Q35692471-17A7B47F-C28D-4027-ABFC-08CEB0C0CC61 Q35707031-57775C6A-8ED0-4BA7-83B2-25E3DD0F991E Q36095080-7B431F40-A632-4E35-92E4-AB12D6BE3B45 Q36208896-1E8D315E-0B2B-4801-A50C-FDD94736832D Q36425300-E43F94E0-DB3D-45F7-8180-02CE206CF893 Q36516021-49D537E0-2144-434F-AB04-B6F9EDAE8FE7 Q37162723-215F6555-FEC1-48D2-8521-67905DAB5BDC Q37312020-1CE45E11-D5D6-49E0-959F-66A38C376959 Q37493998-5F143D3F-3F55-41F7-B7A6-043BB6C81E83 Q37620408-3DD3240A-C175-408E-9016-01D693DCDE74 Q38031216-41272AD5-8D53-4A97-B4D5-D39C193D112C Q38200883-516E3D47-3F58-4602-B09D-70B2F24C2046 Q38545213-15724DC6-4FC6-4DD0-A7F5-EFA29107AFFF Q39049485-16273860-6B2D-41B1-8741-9886AE3939CF Q41574661-D6B52772-8DF9-40D4-8279-34166FAFCFF8 Q45833383-F7FDB170-4E83-40A4-871E-1028568F5281 Q46293116-A34E50B1-FCD7-425D-A37D-CC3BDFDA6047 Q50347097-2C9DAF13-1ECC-4EBD-833E-0B1E1FA35654 Q50420350-CA4E847B-E869-4A87-8AAD-5BF4F8D10163 Q53989980-3DAF0020-CAEB-4CA2-874A-A0E51A8352CB

P2860

Fibroblast growth factor 23 production in bone is directly regulated by 1{alpha},25-dihydroxyvitamin D, but not PTH.

http://www.wikidata.org/entity/Q42925810

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Fibroblast growth factor 23 pr ...... hydroxyvitamin D, but not PTH.

@en

Fibroblast growth factor 23 pr ...... hydroxyvitamin D, but not PTH.

@nl

type

label

Fibroblast growth factor 23 pr ...... hydroxyvitamin D, but not PTH.

@en

Fibroblast growth factor 23 pr ...... hydroxyvitamin D, but not PTH.

@nl

prefLabel

Fibroblast growth factor 23 pr ...... hydroxyvitamin D, but not PTH.

@en

Fibroblast growth factor 23 pr ...... hydroxyvitamin D, but not PTH.

@nl

P1433

Q42925810-0E2C8136-11AF-4729-AB9A-52B9D73019F6

P1476

Q42925810-0C244E90-02A8-4646-98AA-015E6DE27B3F

P2093

Q42925810-006D082F-A169-44AB-BAEF-40B646024B95

Q42925810-01A4131F-7AAF-4DE1-8D03-99C8829CE5F8

Q42925810-5B054D16-7E28-48E0-A921-D4905477F44D

Q42925810-9F7CAE5A-C80B-4811-A55F-D98976FD3F60

Q42925810-BD32C8F2-8641-447F-903D-61C366D141DC

Q42925810-C2467800-1A17-4963-98EA-CDBF56343292

Q42925810-D8846939-83A4-44BC-99C1-4ACED6EE1512

Q42925810-E729A323-C0EE-431C-BDC8-D60AF4DE4ABB

Q42925810-FFD9B4AF-E50D-4562-8388-4AD69068C0BA

P2860

Q42925810-02A76889-FB76-443F-A3A0-1E63F0AF9795

Q42925810-07716592-5578-418A-AD22-E101823AE336

Q42925810-09CCF070-90FC-4558-9F5F-03F56A774501

Q42925810-2E94590B-40F6-4B91-B802-3C23F0413AEF

Q42925810-39102E00-DDCD-4E2B-841B-7369EE48911E

Q42925810-3AA9093B-368D-48AC-BEEE-B476E8EDC452

Q42925810-3BE71E36-EBF6-4180-9042-7036A312E91A

Q42925810-3D4D4D36-57A5-47C7-9D4C-13861EA9740D

Q42925810-3D9ABD7C-CC1D-4B2A-BBAB-0B8117525473

Q42925810-435450DF-AD3F-41D2-BAA8-27F47DCA7485

P304

Q42925810-2E20B70D-8664-4E13-BA9B-1FE9698D1CEB

P31

Q42925810-903E39D7-F33B-48C9-9B73-B4C33027A889

P356

Q42925810-AB53A2F7-2BB0-424E-9E6D-81E94E973B01

P433

Q42925810-3CFD9500-A62B-45CA-BAC9-3AC5957EBC4D

P478

Q42925810-9DA56F57-8893-4D5E-8FD3-BC2B92AE2887

P577

Q42925810-543FEFB6-ADB8-48BB-BF22-92F5BED05194

P698

Q42925810-B6FE51A1-4147-4895-8BDB-F08DB039CF92

P356

AJPRENAL.00169.2010

P1433

American Journal of Physiology - Renal Physiology

P1476

Fibroblast growth factor 23 pr ...... hydroxyvitamin D, but not PTH.

@en

P2093

Fumie Saji

http://www.w3.org/2001/XMLSchema#string

Hikari Orita

http://www.w3.org/2001/XMLSchema#string

Maki Ooura

http://www.w3.org/2001/XMLSchema#string

Masaki Ohya

http://www.w3.org/2001/XMLSchema#string

Shigeo Negi

http://www.w3.org/2001/XMLSchema#string

Takashi Shigematsu

http://www.w3.org/2001/XMLSchema#string

Toru Mima

http://www.w3.org/2001/XMLSchema#string

Toshifumi Sakaguchi

http://www.w3.org/2001/XMLSchema#string

Yuka Maeda

http://www.w3.org/2001/XMLSchema#string

P2860

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro

Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo

Differential regulation of PHEX expression in bone and parathyroid gland by chronic renal insufficiency and 1,25-dihydroxyvitamin D3

Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets

Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene.

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.

Mechanisms of secondary hyperparathyroidism.

Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo.

P304

F1212-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPRENAL.00169.2010

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

299

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20739393

http://www.w3.org/2001/XMLSchema#string